Literature DB >> 8815695

Saquinavir: an HIV proteinase inhibitor.

K Bragman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815695     DOI: 10.1007/978-1-4757-9209-6_28

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Oxidative modifications of kynostatin-272, a potent human immunodeficiency virus type 1 protease inhibitor: potential mechanism for altered activity in monocytes/macrophages.

Authors:  David A Davis; Elizabeth Read-Connole; Kara Pearson; Henry M Fales; Fonda M Newcomb; Jackob Moskovitz; Robert Yarchoan
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities.

Authors:  K E Zhang; E Wu; A K Patick; B Kerr; M Zorbas; A Lankford; T Kobayashi; Y Maeda; B Shetty; S Webber
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  Activity of human immunodeficiency virus type 1 protease inhibitors against the initial autocleavage in Gag-Pol polyprotein processing.

Authors:  David A Davis; Erin E Soule; Katharine S Davidoff; Sarah I Daniels; Nicole E Naiman; Robert Yarchoan
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

Review 4.  Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.

Authors:  Latoya Griffin; Pieter Annaert; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2011-06-22       Impact factor: 3.534

5.  HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors.

Authors:  Abid Qureshi; Akanksha Rajput; Gazaldeep Kaur; Manoj Kumar
Journal:  J Cheminform       Date:  2018-03-09       Impact factor: 5.514

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.